July 18, 2026 Weight loss drugs may improve job prospects and dating odds for one group A weight loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
July 17, 2026 Game-changing cholesterol pill wins FDA approval after cutting LDL nearly 60% Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined with statins.
July 16, 2026 Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders Neurologists warn that GLP-1 weight-loss drugs like semaglutide may accelerate ALS progression by triggering dangerous rapid weight loss in patients.
July 9, 2026 Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health Dr. Mehmet Oz backs GLP-1 weight loss medication but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.
July 3, 2026 What killed Americans in 1776? The answer is dramatically different from today Life expectancy rose from the age of 30 to nearly 80 years. Today, infectious diseases have given way to chronic conditions like heart disease, cancer and diabetes.
July 1, 2026 Big Medicare change slashes weight-loss drug costs for eligible seniors A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing obesity drug costs.
June 26, 2026 Trump’s drug price war with Europe aims to make things cheaper for Americans Trump administration launched a Section 301 investigation into Germany's drug pricing, targeting persistent underpayment for U.S. drugs.
June 20, 2026 Popular weight loss drugs linked to unexpected male fertility benefit GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
June 19, 2026 Poison centers link growing Benadryl abuse among teens to dangerous social media trends America's Poison Centers reports a concerning 31.9% rise in diphenhydramine abuse among teens, with cases reportedly more than doubling in 2026.
June 19, 2026 Weight-loss drugs linked to 'Ozempic ears' and other cosmetic complaints, surgeons say GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and flatter buttocks, surgeons say.